NCT05955261 A Study of Venetoclax in Combination With Conventional Chemotherapy in Pediatric Patients With Acute Myeloid Leukemia Status SUSPENDED Phase PHASE2
NCT05941442 A Study to Evaluate Efficacy, Safety, and Tolerability of Darigabat in Participants With Panic Disorder Status TERMINATED Phase PHASE2
NCT05940402 A Study to Evaluate Pharmacokinetic and Safety Trial of Emraclidine in Participants With Renal Impairment Compared With Participants With Normal Renal Function Status COMPLETED Phase PHASE1
NCT05938985 Croatian Version of the Ocular Surface Disease Index Questionnaire (OSDI) Status UNKNOWN Phase N/A
NCT05935033 A Study to Evaluate the Effect of Hepatic Impairment on the Pharmacokinetics of Emraclidine Status COMPLETED Phase PHASE1
NCT05930275 Study to Assess Speed of Onset and Durability of Effectiveness of Upadacitinib in Adult Participants With Moderate to Severe Crohn's Disease (CD) in Real World Clinical Practice. Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05916157 An Observational Study of Subcutaneous Infusion of ABBV-951 to Assess Change in Disease Activity and Adverse Events In Adult Japanese Participants With Advanced Parkinson's Disease Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05909553 Study to Assess Adverse Events and Compare How Crushed, Ground, and Intact Oral Tablets Venetoclax Moves Through the Body of Healthy Female Adult Volunteers Status COMPLETED Phase PHASE1
NCT05904106 Venetoclax Plus Azacitidine Versus Intensive Chemotherapy for Fit Patients With Newly Diagnosed NPM1 Mutated AML Status RECRUITING Phase PHASE2
NCT05895266 A Study to Assess Drug-Drug Interaction Between ABBV-903 and Midazolam in Adult Healthy Volunteers Status COMPLETED Phase PHASE1
NCT05894109 Efficacy of Zinc Supplementation on Botox Treated Forehead Rhytids Status WITHDRAWN Phase NA
NCT05892757 Study to Assess Adverse Events and Compare How Oral Ubrogepant and Oral Atogepant Moves Through the Body of Healthy Female Adult Volunteers Status COMPLETED Phase PHASE1
NCT05889182 A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy Status RECRUITING Phase PHASE3
NCT05887609 An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib Status RECRUITING Phase PHASE2
NCT05878067 A Study to Assess Symptom Relief and Product Tolerability of ABBV-444 Drops in Adult Participants Status COMPLETED Phase PHASE3
NCT05861427 Study of Oral Atogepant Tablets to Assess Change in Disease Activity in Adult Japanese Participants With Episodic Migraine Status COMPLETED Phase PHASE3
NCT05843643 Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05841537 An Observational Study to Assess Change in Disease Activity and Adverse Events In Adult Participants With Moderate to Severe Active Crohn's Disease (CD) Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05836506 A Study to Assess the Relative Bioavailability of Immediate Release Formulations of ABBV-903 in Healthy Adult Participants Status COMPLETED Phase PHASE1
NCT05833438 Venetoclax in Combination With 5 Days Azacitidine in Untreated AML Patients, Not Eligible for Standard Induction Therapy Status ACTIVE_NOT_RECRUITING Phase PHASE2